University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from barrett's esophagus: Results from biomarkers and genetic variants

Takata, Y, Kristal, AR, King, IB, Lampe, JW, Reid, BJ, Vaughan, TL, Peters, U, Santella, RM, King, IB, Duggan, DJ , Rayman, MP, Blount, PL and Reid, BJ (2012) Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from barrett's esophagus: Results from biomarkers and genetic variants PLoS ONE, 7 (6).

Full text not available from this repository.

Abstract

Clinical trials have suggested a protective effect of selenium supplementation on the risk of esophageal cancer, which may be mediated through the antioxidant activity of selenoenzymes. We investigated whether serum selenium concentrations, selenoenzyme activity, oxidative stress and genetic variation in selenoenzymes were associated with the risk of neoplastic progression to esophageal adenocarcinoma (EA) and two intermediate endpoints, aneuploidy and tetraploidy. In this prospective cohort study, during an average follow-up of 7.3 years, 47 EA cases, 41 aneuploidy cases and 51 tetraploidy cases accrued among 361 participants from the Seattle Barrett's Esophagus Research Study who were free of EA at the time of blood draw and had at least one follow-up visit. Development to EA was assessed histologically and aneuploidy and tetraploidy by DNA content flow cytometry. Serum selenium concentrations were measured using atomic absorption spectrometry, activity of glutathione peroxidase (GPX) 1 and GPX3 by substrate-specific coupled test procedures, selenoprotein P (SEPP1) concentrations and protein carbonyl content by ELISA method and malondialdehyde concentrations by HPLC. Genetic variants in GPX1-4 and SEPP1 were genotyped. Serum selenium was not associated with the risk of neoplastic progression to EA, aneuploidy or tetraploidy (P for trend = 0.25 to 0.85). SEPP1 concentrations were positively associated with the risk of EA [hazard ratio (HR) = 3.95, 95% confidence intervals (CI) = 1.42-10.97 comparing the third tertile with the first] and with aneuploidy (HR = 6.53, 95% CI = 1.31-32.58), but not selenoenzyme activity or oxidative stress markers. No genetic variants, overall, were associated with the risk of neoplastic progression to EA (global p = 0.12-0.69). Our results do not support a protective effect of selenium on risk of neoplastic progression to EA. Our study is the first to report positive associations of plasma SEPP1 concentrations with the risk of EA and aneuploidy, which warrants further investigation. © 2012 Takata et al.

Item Type: Article
Authors :
NameEmailORCID
Takata, YUNSPECIFIEDUNSPECIFIED
Kristal, ARUNSPECIFIEDUNSPECIFIED
King, IBUNSPECIFIEDUNSPECIFIED
Lampe, JWUNSPECIFIEDUNSPECIFIED
Reid, BJUNSPECIFIEDUNSPECIFIED
Vaughan, TLUNSPECIFIEDUNSPECIFIED
Peters, UUNSPECIFIEDUNSPECIFIED
Santella, RMUNSPECIFIEDUNSPECIFIED
King, IBUNSPECIFIEDUNSPECIFIED
Duggan, DJUNSPECIFIEDUNSPECIFIED
Rayman, MPm.rayman@surrey.ac.ukUNSPECIFIED
Blount, PLUNSPECIFIEDUNSPECIFIED
Reid, BJUNSPECIFIEDUNSPECIFIED
Date : 8 June 2012
Identification Number : 10.1371/journal.pone.0038612
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:44
Last Modified : 17 May 2017 14:44
URI: http://epubs.surrey.ac.uk/id/eprint/824899

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800